Skip to main content
logo
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
46.84
+0.17 (0.36%)
At close: Aug 28, 2026, 4:00 PM EDT
46.85
+0.01 (0.02%)
After-hours: Aug 28, 2026, 7:59 PM EDT

Boston Scientific Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,6742,8981,8531,5936981,041
Depreciation & Amortization
1,4131,3681,2691,1961,1361,093
Loss (Gain) From Sale of Assets
----22-78
Asset Writedown & Restructuring Costs
-4638658132370
Loss (Gain) From Sale of Investments
-94-13979591-250
Stock-Based Compensation
320299266233220194
Other Operating Activities
-14230844134322-149
Change in Accounts Receivable
-293-269-351-238-220-279
Change in Inventory
-454-188-228-660-321-346
Change in Accounts Payable
172296243118-255408
Change in Other Net Operating Assets
-67-85-12610-209-134
Operating Cash Flow
4,5294,5343,4352,5031,5261,870
Operating Cash Flow Growth
5.69%31.99%37.23%64.02%-18.40%24.01%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-904-876-790-711-588-554
Sale of Property, Plant & Equipment
----1214
Cash Acquisitions
-1,063-1,593-4,640-1,811-1,542-2,258
Divestitures
----5826
Sale (Purchase) of Intangibles
----7082
Investment in Securities
-1,645-254-280-89-24279
Other Investing Activities
518323375614
Investing Cash Flow
-3,561-2,640-5,687-2,574-2,011-1,597

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--187---
Long-Term Debt Issued
-1,5582,145-3,270-
Total Debt Issued
1,6741,5582,332-3,270-
Short-Term Debt Repaid
--1,791-504-4-251-
Long-Term Debt Repaid
--258-25--3,184-
Total Debt Repaid
-696-2,049-529-4-3,435-
Net Debt Issued (Repaid)
978-4911,803-4-165-
Issuance of Common Stock
221282230182136110
Repurchase of Common Stock
-2,000-----
Preferred Dividends Paid
-----55-55
Dividends Paid
-----55-55
Other Financing Activities
-157-186-219-173-464-150
Financing Cash Flow
-958-3951,8145-548-95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
242-11-4-9-6
Miscellaneous Cash Flow Adjustments
---1--1
Net Cash Flow
121,541-450-70-1,042173

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,6253,6582,6451,7929381,316
Free Cash Flow Growth
4.02%38.30%47.60%91.05%-28.72%16.25%
Free Cash Flow Margin
17.27%18.22%15.79%12.58%7.40%11.07%
Free Cash Flow Per Share
2.432.451.781.220.650.92
Levered Free Cash Flow
2,4513,2421,7881,8501,1552,654
Unlevered Free Cash Flow
2,6783,4601,9782,0161,4492,867

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
319319250259450338
Cash Income Tax Paid
561561656512662302
Change in Working Capital
-642-246-462-770-1,005-351
SEC Filings: 10-K · 10-Q